FDA's 2023 decision to place 19 peptides on “unsafe” list was supported by numerous documented safety concerns.
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
Sen. Bill Cassidy, R-La., issued a report Tuesday on how the Food and Drug Administration can be modernized to do things like encourage medical research. The nearly 20-page report lists more than a ...